Can viruses help us to understand and classify the MHC class I molecules at the maternal-fetal interface?

被引:18
作者
Furman, MH
Ploegh, HL
Schust, DJ
机构
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Fearing Lab,Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA
[2] Harvard Univ, Brigham & Womens Hosp, Sch Med,Div Res Endocrinol & Fertility, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
关键词
placenta; trophoblast; virus; immunoevasion; MHC class I;
D O I
10.1016/S0198-8859(00)00203-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Placental expression of HLA-C, HLA-E, and HLA-G locus products is now well described. However, to date, the functional relevance of these MHC class I products at the maternal-fetal interface is incompletely described. We propose here that HLA-C, -E, and -G comprise a distinct: and cohesive group of MHC class I products. This hypothesis is supported by a growing body of data, including that obtained through the study of viral immune evasion. Continued investigation of viral interactions with MHC class I products promises to help us to define those specific attributes of HLA-C; -E, and -G that define their common characteristics. (C) American Society for Histocompatibility and Immunogenetics, 2000. Published by Elsevier Science Inc.
引用
收藏
页码:1169 / 1176
页数:8
相关论文
共 48 条
[1]  
Avril T, 1999, J IMMUNOL, V162, P5902
[2]   SEVERE HERPESVIRUS INFECTIONS IN AN ADOLESCENT WITHOUT NATURAL-KILLER CELLS [J].
BIRON, CA ;
BYRON, KS ;
SULLIVAN, JL .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (26) :1731-1735
[3]   TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide [J].
Braud, VM ;
Allan, DSJ ;
Wilson, D ;
McMichael, AJ .
CURRENT BIOLOGY, 1998, 8 (01) :1-10
[4]   CONSTRUCTION AND CHARACTERIZATION OF A HUMAN CYTOMEGALOVIRUS MUTANT WITH THE UL18 (CLASS-I HOMOLOG) GENE DELETED [J].
BROWNE, H ;
CHURCHER, M ;
MINSON, T .
JOURNAL OF VIROLOGY, 1992, 66 (11) :6784-6787
[5]   Clinical progression of HIV infection: Role of NK cells [J].
Bruunsgaard, H ;
Pedersen, C ;
Skinhoj, P ;
Pedersen, BK .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1997, 46 (01) :91-95
[6]   HLA and HIV-1:: Heterozygote advantage and B*35-Cw*04 disadvantage [J].
Carrington, M ;
Nelson, GW ;
Martin, MP ;
Kissner, T ;
Vlahov, D ;
Goedert, JJ ;
Kaslow, R ;
Buchbinder, S ;
Hoots, K ;
O'Brien, SJ .
SCIENCE, 1999, 283 (5408) :1748-1752
[7]   Characterization of a murine cytomegalovirus class I major histocompatibility complex (MHC) homolog: Comparison to MHC molecules and to the human cytomegalovirus MHC homolog [J].
Chapman, TL ;
Bjorkman, PJ .
JOURNAL OF VIROLOGY, 1998, 72 (01) :460-466
[8]   The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells [J].
Cohen, GB ;
Gandhi, RT ;
Davis, DM ;
Mandelboim, O ;
Chen, BK ;
Strominger, JL ;
Baltimore, D .
IMMUNITY, 1999, 10 (06) :661-671
[9]   Nonclassical HLA-G molecules are classical peptide presenters [J].
Diehl, M ;
Munz, C ;
Keilholz, W ;
Stevanovic, S ;
Holmes, N ;
Loke, YW ;
Rammensee, HG .
CURRENT BIOLOGY, 1996, 6 (03) :305-314
[10]  
Dorling A, 2000, EUR J IMMUNOL, V30, P586, DOI 10.1002/1521-4141(200002)30:2<586::AID-IMMU586>3.0.CO